107 related articles for article (PubMed ID: 12496937)
1. Action of three ectopeptidases on corticotropin-releasing factor: metabolism and functional aspects.
Ritchie JC; Davis TP; Nemeroff CB
Neuropsychopharmacology; 2003 Jan; 28(1):22-33. PubMed ID: 12496937
[TBL] [Abstract][Full Text] [Related]
2. Kallidin- and bradykinin-degrading pathways in human heart: degradation of kallidin by aminopeptidase M-like activity and bradykinin by neutral endopeptidase.
Kokkonen JO; Kuoppala A; Saarinen J; Lindstedt KA; Kovanen PT
Circulation; 1999 Apr; 99(15):1984-90. PubMed ID: 10209002
[TBL] [Abstract][Full Text] [Related]
3. Molecular cloning of bullfrog corticotropin-releasing factor (CRF): effect of homologous CRF on the release of TSH from pituitary cells in vitro.
Ito Y; Okada R; Mochida H; Hayashi H; Yamamoto K; Kikuyama S
Gen Comp Endocrinol; 2004 Sep; 138(3):218-27. PubMed ID: 15364204
[TBL] [Abstract][Full Text] [Related]
4. Metalloendopeptidase (EC 3.4.24.11) but not angiotensin converting enzyme is involved in the inactivation of substance P by synaptic membranes of the rat substantia nigra.
Oblin A; Danse MJ; Zivkovic B
Life Sci; 1989; 44(20):1467-74. PubMed ID: 2471029
[TBL] [Abstract][Full Text] [Related]
5. The physiology of corticotropin-releasing factor (CRF).
Raux-Demay MC; Girard F
Reprod Nutr Dev (1980); 1985; 25(5):931-43. PubMed ID: 3001878
[TBL] [Abstract][Full Text] [Related]
6. Characterization of hydrolysis of [leu]enkephalin and D-ala2-[L-leu]enkephalin in rat plasma.
Weinberger SB; Martinez JL
J Pharmacol Exp Ther; 1988 Oct; 247(1):129-35. PubMed ID: 2902210
[TBL] [Abstract][Full Text] [Related]
7. Effects of serotonin, cyproheptadine and reserpine on corticotropin-releasing factor release from the rat hypothalamus in vitro.
Nakagami Y; Suda T; Yajima F; Ushiyama T; Tomori N; Sumitomo T; Demura H; Shizume K
Brain Res; 1986 Oct; 386(1-2):232-6. PubMed ID: 3022879
[TBL] [Abstract][Full Text] [Related]
8. Potentiation of des-Arg9-kallidin-induced vasoconstrictor responses by metallopeptidase inhibition in isolated human umbilical artery.
Pelorosso FG; Brodsky PT; Zold CL; Rothlin RP
J Pharmacol Exp Ther; 2005 Jun; 313(3):1355-60. PubMed ID: 15764737
[TBL] [Abstract][Full Text] [Related]
9. Urocortin, a mammalian neuropeptide related to fish urotensin I and to corticotropin-releasing factor.
Vaughan J; Donaldson C; Bittencourt J; Perrin MH; Lewis K; Sutton S; Chan R; Turnbull AV; Lovejoy D; Rivier C
Nature; 1995 Nov; 378(6554):287-92. PubMed ID: 7477349
[TBL] [Abstract][Full Text] [Related]
10. Characterization of a dual inhibitor of angiotensin I-converting enzyme and neutral endopeptidase.
French JF; Flynn GA; Giroux EL; Mehdi S; Anderson B; Beach DC; Koehl JR; Dage RC
J Pharmacol Exp Ther; 1994 Jan; 268(1):180-6. PubMed ID: 8301555
[TBL] [Abstract][Full Text] [Related]
11. Specificity of cultured anterior pituitary cells in detecting corticotropin releasing factor(s): the effect of biologically active peptides and neurotransmitter substances on ACTH release in pituitary cell cultures.
Hashimoto K; Yunoki S; Hosogi H; Takahara J; Ofuji T
Acta Med Okayama; 1979 Apr; 33(2):81-90. PubMed ID: 38634
[TBL] [Abstract][Full Text] [Related]
12. Endothelial angiotensin-converting enzyme and neutral endopeptidase in isolated human umbilical vein: an effective bradykinin inactivation pathway.
Nowak W; Errasti AE; Armesto AR; Santín Velazque NL; Rothlin RP
Eur J Pharmacol; 2011 Sep; 667(1-3):271-7. PubMed ID: 21651905
[TBL] [Abstract][Full Text] [Related]
13. Altered corticosteroid metabolism differentially affects pituitary corticotropin response.
Hanafusa J; Mune T; Tanahashi T; Isomura Y; Suwa T; Isaji M; Daido H; Morita H; Murayama M; Yasuda K
Am J Physiol Endocrinol Metab; 2002 Feb; 282(2):E466-73. PubMed ID: 11788380
[TBL] [Abstract][Full Text] [Related]
14. Kidney ectopeptidases. Structure, functions and clinical significance.
Vlahović P; Stefanović V
Pathol Biol (Paris); 1998 Dec; 46(10):779-86. PubMed ID: 9922994
[TBL] [Abstract][Full Text] [Related]
15. Inactivation of [Leu5]-enkephalin in three isolated preparations: relative importance of aminopeptidase, endopeptidase-24.11 and peptidyl dipeptidase A.
Oka T; Aoki K; Kajiwara M; Ishii K; Kuno Y; Hiranuma T; Matsumiya T
NIDA Res Monogr; 1986; 75():259-62. PubMed ID: 2828976
[TBL] [Abstract][Full Text] [Related]
16. Effects of neutral endopeptidase inhibition and combined angiotensin converting enzyme and neutral endopeptidase inhibition on angiotensin and bradykinin peptides in rats.
Campbell DJ; Anastasopoulos F; Duncan AM; James GM; Kladis A; Briscoe TA
J Pharmacol Exp Ther; 1998 Nov; 287(2):567-77. PubMed ID: 9808682
[TBL] [Abstract][Full Text] [Related]
17. Suppression of hypothalamic-pituitary-adrenal axis responsiveness to stress in a rat model of acute cholestasis.
Swain MG; Patchev V; Vergalla J; Chrousos G; Jones EA
J Clin Invest; 1993 May; 91(5):1903-8. PubMed ID: 8387536
[TBL] [Abstract][Full Text] [Related]
18. Identification of kallidin degrading enzymes in the isolated perfused rat heart.
Wolfrum S; Dendorfer A; Dominiak P
Jpn J Pharmacol; 1999 Jan; 79(1):117-20. PubMed ID: 10082326
[TBL] [Abstract][Full Text] [Related]
19. Non-specific adsorption of corticotrophin-releasing factor (CRF) to powdered glass.
Yasuda N; Greer MA
Acta Endocrinol (Copenh); 1981 Apr; 96(4):433-8. PubMed ID: 6259861
[TBL] [Abstract][Full Text] [Related]
20. Is substance P released from slices of the rat spinal cord inactivated by peptidase(s) distinct from both 'enkephalinase' and 'angiotensin-converting enzyme'?
Mauborgne A; Bourgoin S; Benoliel JJ; Hamon M; Cesselin F
Neurosci Lett; 1991 Feb; 123(2):221-5. PubMed ID: 1709269
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
